Tag: leadless pacing
FDA approves Abbott’s Aveir leadless pacemaker
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Aveir single-chamber (VR) leadless pacemaker for the treatment of patients...
Leadless pacing shows high rate of success at six months
Almost 70% of patients treated with a leadless left ventricular (LV) endocardial pacing system had a favourable clinical response at six months, a post-market...
HRS 2017: Micra reinforces its success in the real world
The Micra leadless pacemaker continues to demonstrate a high implant success rate and a low level of major complications at 30 days in a...
Modular cardiovascular device communication: A step towards artificial intelligence to treat...
The implantable cardioverter defibrillator (ICD) is a well-established therapy for the prevention of sudden cardiac death. However, it is still associated with complications over...
Medtronic announces Medicare reimbursement for Micra Transcatheter Pacing System
Medtronic has announced that the US Centers for Medicare & Medicaid Services (CMS) has approved coverage for the Micra Transcatheter Pacing System (TPS). This...
US Medicare to cover leadless pacemakers
The US Centers for Medicare and Medicaid Services (CMS) have made the decision to cover leadless cardiac pacemakers, as outlined in the agency's final...
Acute and chronic performance of communicating leadless anti-tachycardia pacemaker and S-ICD
Martin Burke (CorVita Science Foundation, Chicago, USA) presents the preclinical acute and chronic performance of the combined implant of a leadless anti-tachycardia pacemaker and...
Medtronic Micra TPS sustains low complication rate through 12 months
New long-term results from the Medtronic Micra Transcatheter System Global Clinical Trial have shown consistently low rates of major complication. The data—from largest and...